Germany-based laboratory services firm Sartorius has expanded its operations with the opening of a new cell culture facility in Puerto Rico, following an investment of USD 33 million. The 2,000 square meter site is designed to manufacture culture media used in the production of protein-based drugs, catering specifically to the America region as production increases over the course of this year.
Expanding Global Network and Enhancing Regional Production
The new plant marks Sartorius’s first manufacturing operation outside of Germany since the company was established in 1983. This strategic move highlights the company’s commitment to expanding its global network, which now encompasses approximately 60 production and sales sites worldwide. The facility in Puerto Rico will play a crucial role in meeting the growing demand for cell culture media in the Americas, supporting the pharmaceutical industry’s need for high-quality production materials.
Boosting Regional Pharmaceutical Production
The establishment of the new cell culture facility in Puerto Rico is a significant step in enhancing regional pharmaceutical production capabilities. Sartorius’s investment not only strengthens the company’s global presence but also contributes to the local economy and the advancement of life sciences in the region. The facility is poised to become a key hub for the production of essential materials used in the development and manufacturing of protein-based drugs, further solidifying Sartorius’s position as a leading supplier in the global life sciences market.-Fineline Info & Tech
